Our findings indicate that CalebinA suppresses this malignant phenotype by inhibiting NF-κB–mediated secretion of IL-8 and VEGF, as well as endothelial tube formation induced by tumor-conditioned media. This evidence concerns the gene NFKB1 and neoplasm.